Digestive System and Oral Physiological Phenomena

18 trials 8 recruiting

Filter these 18 trials by phase, country and sponsor.

Open in Search →

FELICITA - A proof of concept study: open label phase IIa trial evaluating the effect and safety of transplantation of fecal microbiota in c… Pending

2025-520539-17-00 Austistic spectrum disorder 4
Transmission of bacteria from healthy donor stool to the patients gut as first-line treatment of postantibiotic diarrhoea in the critically … Pending

2024-519024-25-00 Postantibiotic diarrhoea in critically ill patients 4
LIVER AKI: A trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with … Recruiting

2025-521457-16-00 descompensated hepatic cirrosis 6 2026-04-21
Crohn's Disease: Pharmacokinetics, Efficacy, and Safety of Risankizumab in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting

2022-502050-14-00 Crohn's disease 5 2024-06-04
ENGIC 02 - PRODIGE 86-FOLFIRINOX SBA- Phase II randomized trial evaluating modified FOLFIRINOX and FOLFOX in the treatment of locally advanc… Recruiting

2023-505486-92-00 Small bowel adenocarcinoma 4 2024-02-09
Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s … Recruiting

2024-517794-24-00 crohn disease 4 2024-10-24
CELLVICROHN study: Is there a concordance between the Cellvizio with an intravenous injection of fluorescein and the pathology to determine … Recruiting

2024-517220-19-00 Crohn's ileal disease 5 2023-10-31
Multicentric trial for the use of indocianine green in patients with acute cholecistitiswho needs urgent surgery. Recruiting

2024-518677-34-00 Emergency cholecystectomy is the gold standard treatmen 6 2023-03-15
Clebopride for the treatment of Rumination Recruiting

2024-516573-71-00 Rumination Syndrome 6 2019-10-03
Prucalopride for refractory gastro-esophageal reflux disease Recruiting

2024-516317-21-00 gastro-esophageal reflux disease 6 2018-04-09
A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary ef… Ended

2024-515907-20-00 Primary biliary cholangitis (PBC) 9 2025-05-23
Study of setmelanotide in patients with obesity with specific genetic variants Ended

2023-507634-24-00 Improper function of certain messenger materials in the 5 2022-05-20
Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN deficiency (CAP… Ended

2023-504998-20-00 Metastatic Hormone-sensitive Prostate Cancer Characteri 5 2020-09-18
Extended Criteria Treatment for Liver Metastases With Heavy Tumour Burden Halted

2024-512397-95-00 Colorectal Liver Metastases 4 2026-05-21
Assessment of the influence of the gut microbiome on tacrolimus pharmacokinetics in healthy volunteers Ended

2023-504405-37-00 Pharmacokinetic trial in healthy volunteers 3 2023-08-02
High-dosage fluoride toothpaste for dental root caries Ended

2022-500059-22-01 Phenomena and Processes (Fluoride in dental caries cont 6 2023-03-24
Study to determine if the investigational drug obeticholic acid (also known as OCA) in combination with the investigational drug bezafibrate… Ended

2024-513584-77-00 Primary biliary cholangitis 4 2023-03-09
"A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJ… Ended

2023-506278-10-00 Eosinophilic esophagitis 5 2022-04-22